Scarica l'app Stockscreener
94.40
0.82%
-0.78
Pre-mercato:
94.31
-0.09
-0.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Schiff launches inquiry into DOJ's closure of probe into Abbott Labs over bacterial contamination at baby formula plant - CBS News
Abbott Laboratories stock stays supported by diversified health-care business - AD HOC NEWS
Abbott Laboratories stock may move 4.5% on earnings release - Investing.com
Abbott Laboratories highlights diagnostics and medical devices as investors assess long-term growth - AD HOC NEWS
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Abbott Laboratories (ABT) Q1 Sales And Guidance Put Fair Value Back In Focus - Yahoo Finance
Abbott Laboratories balances diagnostics demand and investor expectations - Ad-hoc-news.de
Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut? - Insider Monkey
FreeStyle Libre 3 Sensor from Abbott Laboratoriesdiscreet glucose tracking for active diabetes pa - AD HOC NEWS
Is Abbott Laboratories (ABT) Undervalued After Its Glucose Monitoring Growth Narrative? - simplywall.st
Abbott (ABT) Has a Multi-Platform Device-and-Diagnostics Engine Bigger Than the Libre Narrative - AlphaStreet
Trump Admin Stopped Criminal Charges Against Abbott Nutrition for Infant Formula Illnesses - Food Safety Magazine
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with a 22.35% Upside Potential - DirectorsTalk Interviews
DOJ Closing Abbott Labs Case Spurs Wider Corporate Crime Retreat - Bloomberg Law News
Abbott Laboratories Stock (ABT) Opinions on Recent FDA Approvals and Product Launches - Quiver Quantitative
ABT Stock Quote Price and Forecast - CNN
Abbott Labs must face lawsuit over PediaSure children's growth claims - MSN
Abbott Laboratories Q2 Earnings Preview: A Contrarian Buy Opportunity Worth Considering - Seeking Alpha
Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Screen with Strong Growth and Profitability - ChartMill
Is Index Shuffle And Probe Shift Reshaping The Investment Case For Abbott Laboratories (ABT)? - simplywall.st
DOJ ends investigation into infant formula company linked to deadly cronobacter outbreak - foodsafetynews.com
Abbott Laboratories (ABT) Shares Surge 3.5% -- What GF Score of 80 Tells Investors - GuruFocus
Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula - Reuters
Trump Loaded Up on Abbott Laboratories Stock Before His DOJ Dropped Criminal Probe - Common Dreams
A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File. - KFF Health News
Abbott Laboratories (NYSE: ABT) director receives 432 stock equivalent units as deferred fees - Stock Titan
Abbott Laboratories (ABT) director granted 416 stock equivalent units as board fees - Stock Titan
Abbott (ABT) director receives 363 stock equivalent units as board compensation - Stock Titan
Abbott (ABT) director Kevin Conroy receives 231 stock equivalent units as fees - Stock Titan
Form 4 Abbott Laboratories For: 1 July By Investing.com - Investing.com Canada
Abbott Laboratories (ABT) director receives 347 stock equivalent units as board compensation - Stock Titan
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Abbott (NYSE: ABT) EVP withholds 269 shares to satisfy tax obligations - Stock Titan
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott (ABT) Clears A Major Legal Risk As DOJ Ends Criminal Formula Probe - Yahoo Finance
Has Abbott Laboratories (ABT) Fallen Too Far Below Fair Value? - simplywall.st
Baird starts Abbott at Outperform, sees product pipeline driving growth - Yahoo Finance
Baird starts Abbott at Outperform, sees product pipeline driving growth By Investing.com - Investing.com Canada
Abbott Laboratories (ABT) Receives Outperform Rating from Baird with $121 Target - GuruFocus
Abbott Laboratories highlights diversified healthcare portfolio as a long-term driver - AD HOC NEWS
Abbott gains as Baird issues new outperform on growth outlook - MSN
Abbott stock gains as Baird issues new Outperform (ABT:NYSE) - Seeking Alpha
Baird initiates Abbott stock coverage with Outperform rating - Investing.com
Here Are Wednesday’s Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX, and More - Yahoo Finance
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Abbott Laboratories stock underperforms Tuesday when compared to competitors - MarketWatch
US criminal probe into Abbott infant-formula plant closed - Global Food Industry News
Abbott Laboratories earnings calendar, shares in focus on the NYSE - AD HOC NEWS
Enterprise value to EBIT forward of Abbott Laboratories Pakistan Limited – PSX:ABOT - TradingView
Abbott Laboratories was investigated for poisoning babies. After a $500,000 donation, Trump let them off the hook. - More Perfect Union | Substack
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo! Finance Canada
Form 4 Abbott Laboratories For: 29 June By Investing.com - Investing.com Canada
Abbott (ABT) EVP Cushman disposes 560 shares for tax withholding, retains 38,013 - Stock Titan
Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch
Coca Cola Stock And 2 Defensive Picks For Steady Dividends - simplywall.st
MDL Sought for Abbott Spinal Cord Stimulator Lawsuits - AboutLawsuits.com
Price to sales forward of Abbott Laboratories Pakistan Limited – PSX:ABOT - TradingView
How Abbott's Largest Segment Is Preparing for the Next Growth Phase - TradingView
Abbott Laboratories dropped from Russell Top 50, shares hold above Tradegate level - AD HOC NEWS
Abbott Laboratories (ABT) Stock Analysis: Potential 23.82% Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports - WTVB
0.08%
2.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):